Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079313
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2004-03-08
Brief Title:
Imatinib GleevecRegistered Trademark to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
040090
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Heart Lung and Blood Institute NHLBI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Cynthia E Dunbar MDNational Heart Lung and Blood Institute
Old Organization:
National Institutes of Health